Grown Rogue International (GRUSF) Profit After Tax (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) Profit After Tax (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -288.19% |
| Sep 30, 2025 | 199,678,248.12% |
| Jun 30, 2025 | 91.13% |
| Mar 31, 2025 | -100.00% |
| Dec 31, 2024 | 1,959.41% |
| Sep 30, 2024 | -12,049,319.10% |
| Jun 30, 2024 | -32.93% |
| Mar 31, 2024 | -719.50% |
| Oct 31, 2023 | -265.66% |
| Jul 31, 2023 | 83.86% |
| Apr 30, 2023 | -30.47% |
| Jan 31, 2022 | -85.90% |
| Oct 31, 2021 | 358.83% |
| Jul 31, 2021 | -83.34% |
| Apr 30, 2021 | 44.86% |
| Jan 31, 2021 | 913.55% |
| Oct 31, 2020 | 84.59% |
| Jul 31, 2020 | -165.80% |
| Apr 30, 2020 | 617.54% |